Impact of osteopontin on the development of non‐alcoholic liver disease and related hepatocellular carcinoma-Reference-Cited by-同舟云学术

Impact of osteopontin on the development of non‐alcoholic liver disease and related hepatocellular carcinoma

Published:2020-05-30 Issue:7 Volume:40 Page:1620-1633
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Nardo Alexander D.¹^ORCID,Grün Nicole G.¹,Zeyda Maximilian¹²,Dumanic Monika³,Oberhuber Georg⁴,Rivelles Elisa⁵,Helbich Thomas H.³⁶,Markgraf Daniel F.⁷,Roden Michael⁷⁸⁹,Claudel Thierry¹⁰,Trauner Michael¹⁰,Stulnig Thomas M.¹^ORCID

Affiliation:

1. Christian Doppler Laboratory for Cardio‐Metabolic Immunotherapy and Clinical Division of Endocrinology and Metabolism Department of Medicine III Medical University of Vienna Vienna Austria

2. Department of Pediatrics and Adolescent Medicine Medical University of Vienna Vienna Austria

3. Division of Nuclear Medicine Department of Biomedical Imaging and Image‐guided Therapy Medical University of Vienna Vienna Austria

4. Department of Pathology General Hospital of Innsbruck Innsbruck Austria

5. Department of Laboratory Medicine Medical University of Vienna Vienna Austria

6. Division of Molecular and Gender Imaging Department of Biomedical Imaging and Image‐guided Therapy Medical University of Vienna Vienna Austria

7. German Diabetes Center Leibniz Center for Diabetes Research Institute for Clinical DiabetologyHeinrich Heine University Düsseldorf Germany

8. German Center of Diabetes Research (DZD e.V.) München‐Neuherberg Germany

9. Division of Endocrinology and Diabetology Medical Faculty Heinrich‐Heine University Düsseldorf Germany

10. Hans Popper Laboratory of Molecular Hepatology Division of Gastroenterology & Hepatology Medical University of Vienna Vienna Austria

Funder

Austrian Science Fund

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14464

Reference56 articles.

1. Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis

2. Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis

3. Long-term follow-up of patients with NAFLD and elevated liver enzymes

4. Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice

5. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CXCL9, IL2RB, and SPP1, potential diagnostic biomarkers in the co-morbidity pattern of atherosclerosis and non-alcoholic steatohepatitis;Scientific Reports;2024-07-16

2. Identifying the Crucial Biomarker of MASH-Related HCC;Combinatorial Chemistry & High Throughput Screening;2024-05-09

3. Inflammatory liver diseases and susceptibility to sepsis;Clinical Science;2024-04

4. Repaglinide restrains HCC development and progression by targeting FOXO3/lumican/p53 axis;Cellular Oncology;2024-02-07

5. Identification of Potential Diagnostic and Prognostic Biomarkers for Cervical Cancer;2023-10-28